SB 2280 Hawaii Senate · 2020 Regular Session

RELATING TO PHARMACY BENEFIT MANAGERS.

Summary
Prohibits certain contracts for managed care entered into after June 30, 2020, from containing a provision that authorizes a pharmacy benefit manager to reimburse a contracting pharmacy on a maximum allowable cost basis, and voids any such provisions in existing managed care contracts. Prohibits pharmacy benefit managers from engaging in self-serving or deceptive business practices. Prohibits pharmacy benefit managers from engaging in unfair methods of competition or unfair practices. Prohibits pharmacy benefit managers from retaining any portion of spread pricing. Prohibits a pharmacy benefit manager from reimbursing a 340B pharmacy differently than any other network pharmacy. Prohibits a pharmacy benefit manager from reimbursing an independent or rural pharmacy an amount less than the rural rate for each drug under certain circumstances. Prohibits a pharmacy benefit manager from prohibiting a pharmacist to provide certain information to insureds. Increases pharmacy benefit managers' annual reporting requirements. Requires the insurance commissioner to file annual reports with the legislature. Increases pharmacy benefit manager registration and renewal fees. Makes certain violations of pharmacy benefit managers subject to the penalties provided in chapter 480 and chapter 481, Hawaii Revised Statutes. (SD1)
Bill status passed 3 of 5 stages cleared
Introduction
Jan 2020
Committee Review
Mar 2020
Senate Passage
Mar 2020
House Passage
Governor
Introduced Jan 17, 2020 Last action Mar 9, 2020
Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
19
Key actions
9
Committee
12
Mar 9, 2020
Committee
Referred to HLT/LAB, CPC, FIN, referral sheet 36
lower
Mar 3, 2020
Introduced
Received from Senate (Sen. Com. No. 186) in amended form (SD 1).
lower
Mar 3, 2020
Upper · Passed
Report Adopted; Passed Third Reading. Ayes, 25; Aye(s) with reservations: none. Noes, 0 (none). Excused, 0 (none). Transmitted to House.
upper
Feb 25, 2020
Upper · Passed
The committee(s) on JDC recommend(s) that the measure be PASSED, UNAMENDED. The votes in JDC were as follows: 3 Aye(s): Senator(s) K. Rhoads, J.Keohokalole, Kim; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Gabbard, Fevella.
upper
Feb 21, 2020
Upper · Passed
The committee(s) on JDC will hold a public decision making on 02-25-20 12:30PM in conference room 016.
upper
Feb 14, 2020
Committee
Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC.
upper
Feb 14, 2020
Committee
Reported from CPH (Stand. Com. Rep. No. 2747) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC.
upper
Feb 12, 2020
Upper · Passed
The committee(s) on CPH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPH were as follows: 5 Aye(s): Senator(s) Baker, S. Chang, Nishihara, L. Thielen, Wakai; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Ruderman, Fevella.
upper
Feb 11, 2020
Upper · Passed
The committee(s) on CPH deferred the measure until 02-12-20 10:00AM in conference room 229.
upper
Feb 7, 2020
Upper · Passed
The committee(s) on CPH deferred the measure until 02-11-20 10:15AM in conference room 229.
upper
Jan 31, 2020
Upper · Passed
The committee(s) on CPH deferred the measure until 02-07-20 9:30AM in conference room 229.
upper
Jan 28, 2020
Upper · Passed
The committee(s) on CPH deferred the measure until 01-31-20 9:30AM in conference room 229.
upper
Jan 24, 2020
Upper · Passed
The committee(s) on CPH has scheduled a public hearing on 01-28-20 9:00AM in conference room 229.
upper
Jan 21, 2020
Committee
Referred to CPH, JDC.
upper
Jan 17, 2020
Introduced
Introduced.
upper
6 primary · 0 co-sponsors

Sponsors